Skip to main content

Advertisement

Figure 6 | Journal of Ovarian Research

Figure 6

From: The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer

Figure 6

Tumor tissue content of GPER related to histological and clinical parameters TMA of 150 malignant primary ovarian tumors were immunostained for GPER. A) Each histological type and grade as well as clinical stage was stratified as GPER positive samples (score 2-9) vs. GPER negative samples (score 0-1). The distribution of GPER positive samples was not different between histological types, differentiation grades, or clinical stages. B) Kaplan-Meier curves of overall survival for patients showed no difference between GPER positive and GPER negative tumors.

Back to article page